Global Next-Generation Tumor Genetic Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI04241220

Publication Date:

April 8, 2024

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Next-Generation Tumor Genetic Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
publisher' newest research report, the 鈥淣ext-Generation Tumor Genetic Testing Industry Forecast鈥� looks at past sales and reviews total world Next-Generation Tumor Genetic Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Next-Generation Tumor Genetic Testing sales for 2024 through 2030. With Next-Generation Tumor Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Tumor Genetic Testing industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Tumor Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Tumor Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Next-Generation Tumor Genetic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Tumor Genetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Tumor Genetic Testing.
United States market for Next-Generation Tumor Genetic Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Next-Generation Tumor Genetic Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Next-Generation Tumor Genetic Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Next-Generation Tumor Genetic Testing players cover Devyser, Agendia, Illumina, Personal Genome Diagnostics and Veracyte, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Tumor Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Segmentation by application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Next-Generation Tumor Genetic Testing Market Size 2019-2030
2.1.2 Next-Generation Tumor Genetic Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Next-Generation Tumor Genetic Testing Segment by Type
2.2.1 Fluorescence In Situ Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Microarray Technology
2.2.4 Serum Proteomics
2.2.5 Nucleic Acid Sequencing
2.3 Next-Generation Tumor Genetic Testing Market Size by Type
2.3.1 Next-Generation Tumor Genetic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Next-Generation Tumor Genetic Testing Market Size Market Share by Type (2019-2024)
2.4 Next-Generation Tumor Genetic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Speciality Clinics
2.4.3 Research Institutes
2.4.4 Diagnostics Laboratories
2.4.5 Biopharmaceutical Companies
2.5 Next-Generation Tumor Genetic Testing Market Size by Application
2.5.1 Next-Generation Tumor Genetic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Next-Generation Tumor Genetic Testing Market Size Market Share by Application (2019-2024)
3 Next-Generation Tumor Genetic Testing Market Size by Player
3.1 Next-Generation Tumor Genetic Testing Market Size Market Share by Players
3.1.1 Global Next-Generation Tumor Genetic Testing Revenue by Players (2019-2024)
3.1.2 Global Next-Generation Tumor Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Next-Generation Tumor Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Next-Generation Tumor Genetic Testing by Regions
4.1 Next-Generation Tumor Genetic Testing Market Size by Regions (2019-2024)
4.2 Americas Next-Generation Tumor Genetic Testing Market Size Growth (2019-2024)
4.3 APAC Next-Generation Tumor Genetic Testing Market Size Growth (2019-2024)
4.4 Europe Next-Generation Tumor Genetic Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Next-Generation Tumor Genetic Testing Market Size by Country (2019-2024)
5.2 Americas Next-Generation Tumor Genetic Testing Market Size by Type (2019-2024)
5.3 Americas Next-Generation Tumor Genetic Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Tumor Genetic Testing Market Size by Region (2019-2024)
6.2 APAC Next-Generation Tumor Genetic Testing Market Size by Type (2019-2024)
6.3 APAC Next-Generation Tumor Genetic Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Next-Generation Tumor Genetic Testing by Country (2019-2024)
7.2 Europe Next-Generation Tumor Genetic Testing Market Size by Type (2019-2024)
7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Next-Generation Tumor Genetic Testing by Region (2019-2024)
8.2 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Next-Generation Tumor Genetic Testing Market Forecast
10.1 Global Next-Generation Tumor Genetic Testing Forecast by Regions (2025-2030)
10.1.1 Global Next-Generation Tumor Genetic Testing Forecast by Regions (2025-2030)
10.1.2 Americas Next-Generation Tumor Genetic Testing Forecast
10.1.3 APAC Next-Generation Tumor Genetic Testing Forecast
10.1.4 Europe Next-Generation Tumor Genetic Testing Forecast
10.1.5 Middle East & Africa Next-Generation Tumor Genetic Testing Forecast
10.2 Americas Next-Generation Tumor Genetic Testing Forecast by Country (2025-2030)
10.2.1 United States Next-Generation Tumor Genetic Testing Market Forecast
10.2.2 Canada Next-Generation Tumor Genetic Testing Market Forecast
10.2.3 Mexico Next-Generation Tumor Genetic Testing Market Forecast
10.2.4 Brazil Next-Generation Tumor Genetic Testing Market Forecast
10.3 APAC Next-Generation Tumor Genetic Testing Forecast by Region (2025-2030)
10.3.1 China Next-Generation Tumor Genetic Testing Market Forecast
10.3.2 Japan Next-Generation Tumor Genetic Testing Market Forecast
10.3.3 Korea Next-Generation Tumor Genetic Testing Market Forecast
10.3.4 Southeast Asia Next-Generation Tumor Genetic Testing Market Forecast
10.3.5 India Next-Generation Tumor Genetic Testing Market Forecast
10.3.6 Australia Next-Generation Tumor Genetic Testing Market Forecast
10.4 Europe Next-Generation Tumor Genetic Testing Forecast by Country (2025-2030)
10.4.1 Germany Next-Generation Tumor Genetic Testing Market Forecast
10.4.2 France Next-Generation Tumor Genetic Testing Market Forecast
10.4.3 UK Next-Generation Tumor Genetic Testing Market Forecast
10.4.4 Italy Next-Generation Tumor Genetic Testing Market Forecast
10.4.5 Russia Next-Generation Tumor Genetic Testing Market Forecast
10.5 Middle East & Africa Next-Generation Tumor Genetic Testing Forecast by Region (2025-2030)
10.5.1 Egypt Next-Generation Tumor Genetic Testing Market Forecast
10.5.2 South Africa Next-Generation Tumor Genetic Testing Market Forecast
10.5.3 Israel Next-Generation Tumor Genetic Testing Market Forecast
10.5.4 Turkey Next-Generation Tumor Genetic Testing Market Forecast
10.5.5 GCC Countries Next-Generation Tumor Genetic Testing Market Forecast
10.6 Global Next-Generation Tumor Genetic Testing Forecast by Type (2025-2030)
10.7 Global Next-Generation Tumor Genetic Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Devyser
11.1.1 Devyser Company Information
11.1.2 Devyser Next-Generation Tumor Genetic Testing Product Offered
11.1.3 Devyser Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Devyser Main Business Overview
11.1.5 Devyser Latest Developments
11.2 Agendia
11.2.1 Agendia Company Information
11.2.2 Agendia Next-Generation Tumor Genetic Testing Product Offered
11.2.3 Agendia Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agendia Main Business Overview
11.2.5 Agendia Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Next-Generation Tumor Genetic Testing Product Offered
11.3.3 Illumina Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Information
11.4.2 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product Offered
11.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Personal Genome Diagnostics Main Business Overview
11.4.5 Personal Genome Diagnostics Latest Developments
11.5 Veracyte
11.5.1 Veracyte Company Information
11.5.2 Veracyte Next-Generation Tumor Genetic Testing Product Offered
11.5.3 Veracyte Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Veracyte Main Business Overview
11.5.5 Veracyte Latest Developments
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Information
11.6.2 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product Offered
11.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pacific Biosciences of California Main Business Overview
11.6.5 Pacific Biosciences of California Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Next-Generation Tumor Genetic Testing Product Offered
11.7.3 Qiagen Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Next-Generation Tumor Genetic Testing Product Offered
11.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Natera
11.9.1 Natera Company Information
11.9.2 Natera Next-Generation Tumor Genetic Testing Product Offered
11.9.3 Natera Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Natera Main Business Overview
11.9.5 Natera Latest Developments
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Information
11.10.2 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product Offered
11.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio Rad Laboratories Main Business Overview
11.10.5 Bio Rad Laboratories Latest Developments
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Information
11.11.2 Myriad Genetics Next-Generation Tumor Genetic Testing Product Offered
11.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Myriad Genetics Main Business Overview
11.11.5 Myriad Genetics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂